Persistent Hyperphosphataemia as a Surrogate Marker of Permanent Hypoparathyroidism After Total Thyroidectomy in a Resource‐Limited Setting
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Permanent hypoparathyroidism remains a significant complication after total thyroidectomy (TT), particularly with rising thyroid cancer incidence and increasing surgical extent. Long-term consequences include hypocalcaemic symptoms, renal impairment, cardiovascular morbidity, neurocognitive dysfunction, reduced quality of life, and increased healthcare utilization. Although intact parathyroid hormone (iPTH) is the standard biomarker for diagnosis and surveillance, its availability and affordability remain limited in many low-resource settings. This prospective study evaluated the utility of serum phosphate as a surrogate marker for permanent hypoparathyroidism after TT. METHODS: This cohort study compared patients with and without permanent hypoparathyroidism, defined as iPTH < 10 pg/mL persisting beyond 6 months post-TT. Demographic, clinico-pathological, and biochemical variables, including serum calcium, phosphate, iPTH, and 25-hydroxyvitamin D (25OHD), were analyzed at baseline, postoperative day 2 (POD2), and 6 months. RESULTS: Among 328 patients (mean age 38.7 years; 77.1% women), transient postoperative hypoparathyroidism occurred in 195 (59.5%) and permanent hypoparathyroidism in 18 (5.5%). Multivariable analysis identified POD2 iPTH (odds ratio 10.7, 95% confidence intervals 1.3-88.1); parathyroid autotransplantation (OR 8.4[1.6-43.5]); six-month phosphate (OR 3.9[1.2-13.5]); six-month 25OHD level (OR 3.2[1.03-10.1]) and POD2 calcium (OR 1.7[1.0-3.0]) as independent predictors, each p < 0.05. In receiver operating characteristic analysis, both POD2 iPTH < 6 pg/mL (AUC = 0.781) and 6-month phosphate > 4.9 mg/dL (AUC = 0.743) demonstrated good discriminatory performance (p < 0.001) and were comparable by DeLong's test (p = 0.671). CONCLUSION: Postoperative iPTH below 6 pg/mL is the principal marker for early risk stratification of permanent hypoparathyroidism following TT, whereas persistent hyperphosphataemia may serve as a surrogate biochemical marker during long-term surveillance.
Source: World Journal of Surgery
DOI: 10.1002/wjs.70683
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: permanent hypoparathyroidism, total thyroidectomy, hyperphosphatemia, serum phosphorus, surrogate markers, parathyroid hormone, parathyroid autotransplantation, 25-hydroxyvitamin D, postoperative hypocalcemia, thyroid cancer surgery, resource-limited settings, risk stratification, postoperative day 2, renal dysfunction, cardiovascular morbidity
Open Access status: bronze
OpenAlex ID: W7227905294
